Cargando…
In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds
BACKGROUND: About 425 million adults had diabetes mellitus globally in 2017. Type 2 diabetes accounts for the enormous majority of diabetes cases and it is gradually growing which is predicted to increase by 48% in 2045. Imbalanced cellular carbohydrate and lipid metabolism cause an increase in post...
Autores principales: | Tekulu, Gebretsadkan Hintsa, Araya, Ephrem Mebrahtu, Mengesha, Hayelom Gebrekirstos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686372/ https://www.ncbi.nlm.nih.gov/pubmed/31391018 http://dx.doi.org/10.1186/s12906-019-2622-5 |
Ejemplares similares
-
Evaluation of Antimalarial Activity of the Leaf Latex and TLC Isolates from Aloe megalacantha Baker in Plasmodium berghei Infected Mice
por: Hintsa, Gebretsadkan, et al.
Publicado: (2019) -
Antihyperglycemic Activity of TLC Isolates from the Leaves of Aloe megalacantha Baker in Streptozotocin-Induced Diabetic Mice
por: Araya, Tsgabu Yohannes, et al.
Publicado: (2021) -
Antibacterial and Antifungal Activities of the Leaf Exudate of Aloe megalacantha Baker
por: Asmerom, Demoze, et al.
Publicado: (2020) -
Cytotoxic Compounds from Aloe megalacantha
por: Abdissa, Negera, et al.
Publicado: (2017) -
In Vivo Wound Healing and Anti-Inflammatory Activities of Leaf Latex of Aloe megalacantha Baker (Xanthorrhoeaceae)
por: Gebremeskel, Leake, et al.
Publicado: (2018)